APLS vs TEL · rev $781.4M vs P/E 39, rev $17.26B
Apellis Pharmaceuticals Inc (APLS) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
APLS currently screens at market cap $2.29B. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the APLS and TEL stock pages for the full models.
Not investment advice.